Hydroxycarbamide: Clinical aspects

Comptes Rendus - Biologies

Volumn 336, Issue 3, 2013, Pages 177-182

  Ware, Russell E ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Hydroxyurea; Sickle cell anemia

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ANEMIA; CARBAMATE (ESTER); CELL ORGANELLE; CHILD HEALTH; DISEASE TREATMENT; HEMOGLOBIN; MONITORING; REMEDIATION; TOLERANCE; TOXICITY;

ARTICLE; CARCINOGENICITY; CEREBROVASCULAR ACCIDENT; CYTOPENIA; DEVELOPING COUNTRY; DRUG DOSE ESCALATION; DRUG ERUPTION; FOLLOW UP; HUMAN; HYPERPIGMENTATION; MAXIMUM TOLERATED DOSE; MYELODYSPLASTIC SYNDROME; NEWBORN SCREENING; SICKLE CELL ANEMIA; SKIN ULCER; TREATMENT INDICATION; TREATMENT RESPONSE;

AFRICA;

EID: 84877578186     PISSN: 16310691     EISSN: 17683238     Source Type: Journal    
DOI: 10.1016/j.crvi.2012.09.006     Document Type: Short Survey

References (21)

1. S.J. Marcus, and R.E. Ware Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention J. Pediatr. Hematol./Oncol. 21 5 1999 407 411
2. A.K. Brown, L.A. Sleeper, S.T. Miller, C.H. Pegelow, F.M. Gill, and M.A. Waclawiw Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease Arch. Pediatr. Adolesc. Med 148 8 1994 796 804
3. D. Powars, and A. Hiti Sickle cell anemia. Beta-S gene cluster haplotypes as genetic markers for severe disease expression Am. J. Dis. Child. 147 11 1993 1197 1202
4. G. Lettre, V.G. Sankaran, and M.A. Bezerra DNA polymorphism at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease Proc. Natl Acad. Sci. USA 105 33 2008 11869 11874
5. O.S. Platt, S.H. Orkin, G. Dover, G.P. Beardsley, B. Miller, and D.G. Nathan Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia J. Clin. Invest. 74 2 1984 652 656
6. R.E. Ware How I use hydroxyurea to treat young patients with sickle cell anemia Blood 115 26 2010 5300 5311
7. S. Charache, M.L. Terrin, and R.D. Moore Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia N. Engl. J. Med. 332 20 1995 1317 1322
8. T.R. Kinney, R.W. Helms, and E.E. O'Branski Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group Blood 94 5 1999 1550 1554
9. W.C. Wang, R.E. Ware, and S.T. Miller Hydroxycarbamide in very young children with sickle-cell anaemia: a multicenter, randomized, controlled trial (BABY HUG) Lancet 377 9778 2011 1663 1672
10. W.C. Wang, L.W. Wynn, Z.R. Rogers, J.P. Scott, P.A. Lane, and R.E. Ware A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia J. Pediatr. 139 6 2001 790 796
11. M.M. Heeney, and R.E. Ware Hydroxyurea for children with sickle cell disease Pediatr. Clin. North Am. 55 2 2008 483 501
12. R.E. Ware, and B. Aygun Advances in the use of hydroxyurea Am. Soc. Hematol. Educ. Program 2009 62 69
13. S. Charache, G.J. Dover, and R.D. Moore Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia Blood 79 10 1992 2555 2565
14. R.E. Ware, and R.W. Helms For the SWiTCH Investigators. Stroke with transfusions changing to hydroxyurea (SWiTCH) Blood 119 17 2012 3925 3932
15. W.H. Schultz, and R.E. Ware Malignancy in sickle cell disease Am. J. Hematol. 74 4 2003 249 253
16. S.K. Ballas, W.F. McCarthy, and N. Guo Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia J. Natl Med. Assoc. 101 10 2009 1046 1051
17. M.H. Steinberg, W.F. McCarthy, and O. Castro The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5-year follow-up Am. J. Hematol. 85 6 2010 403 408
18. E. Voskaridou, D. Christoulas, and A. Bilalis The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS) Blood 115 12 2010 2354 2363
19. D.J. Weatherall The inherited diseases of hemoglobin are an emerging global health burden Blood 115 22 2010 4331 4336
20. R.E. Ware, J.M. Despotovic, and N.A. Mortier Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia Blood 118 18 2011 4985 4991
21. P.T. McGann, and R.E. Ware Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr. Opin. Hematol. 18 3 2011 158 165